Elizabeth Fleming

Elizabeth Fleming, PhD, is a versatile life sciences professional currently serving as the Chief Scientific Officer at Senaptec, where they create and manage programs focused on diagnostic and therapeutic technologies in neurology. They previously worked as a Scientific Consultant and Grant Writing Specialist at Eva Garland Consulting, LLC, providing strategic guidance and writing competitive grant applications. Elizabeth gained valuable research experience as a Graduate Research Assistant at Duke University, where they made significant discoveries in neurobiology, and as a Research Assistant at Massachusetts General Hospital, co-authoring publications on peanut allergy. Elizabeth holds a PhD in Neurobiology from Duke University and a BA in Biology and French from Berea College.